Legal & General Group’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,831
| Closed | -$17.7K | – | 3558 |
|
|
2023
Q1 | $17.7K | Hold |
2,831
| – | – | ﹤0.01% | 3098 |
|
|
2022
Q4 | $17.2K | Hold |
2,831
| – | – | ﹤0.01% | 3186 |
|
|
2022
Q3 | $34K | Buy |
2,831
+345
| +14% | +$4.14K | ﹤0.01% | 3069 |
|
|
2022
Q2 | $31K | Sell |
2,486
-1,739
| -41% | -$21.7K | ﹤0.01% | 3109 |
|
|
2022
Q1 | $48K | Hold |
4,225
| – | – | ﹤0.01% | 3012 |
|
|
2021
Q4 | $75K | Hold |
4,225
| – | – | ﹤0.01% | 2964 |
|
|
2021
Q3 | $97K | Buy |
4,225
+3,102
| +276% | +$71.2K | ﹤0.01% | 2856 |
|
|
2021
Q2 | $26K | Sell |
1,123
-247
| -18% | -$5.72K | ﹤0.01% | 3197 |
|
|
2021
Q1 | $42K | Buy |
+1,370
| New | +$42K | ﹤0.01% | 2876 |
|